Jordan's Hikma Buys Majority of Promopharm Of Morocco
This article was originally published in PharmAsia News
Executive Summary
Jordan's Hikma Pharmaceuticals said it has bought most of Morocco's Promopharm for $111.2 million, with plans to buy all of it